European Pharmaceutical Review

APRIL 17, 2024

In the rapid sterility testing industry, the membrane filtration segment dominated the market , the author stated. Leading players are investing “heavily” in R&D to expand their product lines and will contribute to growth of the market, the author shared. For example, this is due to demand for liquid formulations.

Marketing 90

Marketing Safety Pharmaceutical Medicine 90

European Pharmaceutical Review

MARCH 27, 2024

For example, advanced instruments facilitate faster turnaround, increase reliability of test results and also offer benefit in terms of reducing human error, the authors shared. During a market recession, companies put less investment in R&D and consequently, this potentially slows the production of drugs, the authors shared.

Safety 76

Safety Marketing Food and Drug Administration Pharmaceutical 76

European Pharmaceutical Review

FEBRUARY 20, 2024

The authors also noted that growth of the upstream bioprocessing market is being pushed by the need for process improvement, and because “processing equipment consumption has expanded”.

Marketing 86

Marketing Manufacturing Media Pharmaceutical 86

European Pharmaceutical Review

AUGUST 30, 2023

Therefore, this is expected to boost the market demand, according to the authors. Key players in the market include bioMérieux SA, Charles River Laboratories International, Lonza Group AG, Merck KGaA, Thermo Fisher Scientific, Inc., Eurofins Scientific S.E. Hoffmann-La Roche Ltd.

Manufacturing 95

Manufacturing Marketing Medicine Government 95

European Pharmaceutical Review

SEPTEMBER 6, 2023

According to the authors, North America will remain the fastest growing region over the forecast period. In the research, Thermo Fisher Scientific, Bruker Corporation and Agilent Technologies were reported as some of the key players in the global Raman spectroscopy market.

Marketing 89

Marketing Distribution Pharmaceutical products Media 89

European Pharmaceutical Review

APRIL 3, 2024

This is due to these companies looking to meet to the varied needs of pharmaceutical developers, according to the authors. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market.

Manufacturing 52

Manufacturing Pharmaceutical Marketing 52

European Pharmaceutical Review

APRIL 17, 2023

According to the authors of the report, clinical trials are a key driver of demand for automated solutions, due to the requirement of large quantities of high-quality drugs to be produced quickly and accurately. Sartorius Stedim Biotech SA, Siemens Healthineers and Thermo Fisher Scientific Inc.

Biopharma 95

Biopharma Manufacturing Pharmaceutical products Marketing 95